Brussels, 30 August 2010 - Eucomed, the European Medical Technology Industry association, welcomes the European Commission's (EC) report on the reprocessing of medical devices. While remaining typically neutral in terms of action at this stage of the debate, the EC report confirmed that even with all the evidence and scientific opinion available "...it is not possible to quantify the risk associated with the use of reprocessed single use medical device." Nor was there a comforting picture on the ethics, where the balance between informed consent of patients and the cost saving to the healthcare services could not be determined. Read more...
An experimental biosynthetic cornea implanted in 10 Swedish patients with significant vision loss has dramatically improved their sight and could be a potential alternative to cadaver corneas for curing vision loss due to corneal inflammation and scarring, a new study from researchers in Canada and Sweden reports. Read more...
Scientists have developed a material for bone grafts that could one day replace the 'gold standard' natural bone implants.
The researchers, from the School of Engineering and Materials Science at Queen Mary, University of London and the University of Twente (Enschede, Netherlands), show how particles of calcium phosphate, the primary component of bone ash, can stimulate bone regrowth by attracting stem cells and growth factors to promote healing and the integration of the grafted tissue [...] Read more...
